HemaSphere
(Oct 2023)
ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic Leukemia
- Inge van Outersterp,
- Vincent H.J. van der Velden,
- Patricia G. Hoogeveen,
- Goda E. Vaitkevičienė,
- Edwin Sonneveld,
- Gijs van Haaften,
- Roland P. Kuiper,
- Udo zur Stadt,
- Gabriele Escherich,
- Judith M. Boer,
- Monique L. den Boer
Affiliations
- Inge van Outersterp
- 1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Vincent H.J. van der Velden
- 2 Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands
- Patricia G. Hoogeveen
- 2 Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands
- Goda E. Vaitkevičienė
- 3 Faculty of Medicine, Vilnius University, Lithuania
- Edwin Sonneveld
- 1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Gijs van Haaften
- 6 Department of Genetics, University Medical Center Utrecht, The Netherlands
- Roland P. Kuiper
- 1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Udo zur Stadt
- 7 Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Germany
- Gabriele Escherich
- 7 Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Germany
- Judith M. Boer
- 1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Monique L. den Boer
- 1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- DOI
-
https://doi.org/10.1097/HS9.0000000000000967
- Journal volume & issue
-
Vol. 7,
no. 10
p.
e967
WeChat QR code